selected publications
- Integrative genomic analysis identifies unique immune environments associated with immunotherapy response in diffuse large B cell lymphoma. 2024 GET IT
- T cell states, repertoire and function in classical Hodgkin lymphoma revealed through single-cell analyses. Cancer immunology research. 2024 Academic Article GET IT
- CD5 Gene Signature Identifies Diffuse Large B-Cell Lymphomas Sensitive to Bruton's Tyrosine Kinase Inhibition. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2023 Academic Article GET IT
-
TIGIT is a key inhibitory checkpoint receptor in lymphoma.
Journal for immunotherapy of cancer.
2023
Academic Article
GET IT
Times cited: 4 -
Dendritic cells can prime anti-tumor CD8+ T cell responses through major histocompatibility complex cross-dressing.
2022
GET IT
Times cited: 2 -
Dendritic cells can prime anti-tumor CD8+ T cell responses through major histocompatibility complex cross-dressing.
Immunity.
2022
Academic Article
GET IT
Times cited: 47 -
PD-L1 gene alterations identify a subset of diffuse large B-cell lymphoma harboring a T-cell-inflamed phenotype.
Blood.
2019
Academic Article
GET IT
Times cited: 84